Advanced Tissue Sciences, Inc.
Advised on the sale of Segenix intellectual property rights to RegeneMed, Inc.
M&A
Advanced Tissue Sciences, Inc.
Advised on its restructuring pursuant to Chapter 11.
Restructuring
Advanced Tissue Sciences, Inc.
Advised on the sale of the Nouricel product line to SkinMedica and the sale of intellectual property rights to Smith&Nephew Wound Healing.
M&A
American Home Products, Inc.
Advised on the sale of its Storz Instrument Co. subsidiary to Bausch & Lomb.
M&A
American Shared Hospital Services
Advised on its Chapter 11 financial restructuring.
Restructuring
ATS Liquidating Trust
Divestiture of substantially all assets pursuant to Chapter 11 plan of reorganization.
Valuation & Fairness
Baylor College of Medicine
Provided expert valuation testimony in support of an insurance recovery claim during litigation.
Valuation & Fairness
Beverly Enterprises, Inc. (Appaloosa Management LP, Franklin Mutual Advisors, LLC, Formation Capital, LLC)
Initiated and advised activist shareholder group on equity investment and potential acquisition of Beverly Enterprises.
M&A & Capital Raise
Brentwood Medical Products, Inc.
Advised on its sale to Midmark Corporation.
M&A
Columbia Hospital Corporation
Advised on a secondary offering of common stock.
Capital Raise
EDIX Corporation
Advised on the acquisition of Transcription Ltd.
M&A
EyeCare Service Plan, Inc.
Advised on its sale to Spectera, Inc.
M&A
Genetech, Inc.
Provided expert testimony during litigation to assist in defending claims concerning Genetech's blockbuster treatment for vision loss.
Valuation & Fairness
Gen-Probe, Inc.
Provided expert damage testimony in support of patent infringement litigation against Bayer Healthcare.
Valuation & Fairness
Huntingdon plc
Advised on its approximately $43 million acquisition of US and UK toxicology operations from Applied Bioscience International, and the related UK equity offering and debt facility.
M&A & Restructuring
Integrated Health Services, Inc.
Advised on $1 billion spin-off of Rotech Medical Corporation.
M&A
Integrated Health Services, Inc.
Advised on the sale of Long-Term Care and Contract Rehabilitation Services businesses to ABE Briarwood Corp. for approx $220 million.
M&A
Integrated Health Services, Inc.
Advised on its Chapter 11 financial restructuring.
Restructuring
Integrated Health Services, Inc.
Advised on sale of a minority interest in APS Holdings Corporation to U.S. Bioservices Corporation for approximately $12 million.
M&A
Integrated Health Services, Inc.
Advised on sale of Litho Group, Inc. to Healthtronics, Inc. for approximately $43 million.
M&A
IHS Liquidating, LLC
As liquidating managers, have returned over $75 million to unsecured creditors through sales of assets, collection of collateral and pursuit of litigation claims against various constituencies.
Consulting
Invitrogen
Valuation of business for IRC 338 Allocation.
Valuation & Fairness
Kindred Healthcare, Inc.
Advised on its acquisition for resale of 8 skilled nursing facilities and 2 long-term acute care hospitals from Ventas, Inc. for a total consideration of approximately $85 million.
M&A
Kindred Healthcare, Inc.
Advised on its acquisition for resale of 17 Florida and Texas skilled nursing facilities from Ventas, Inc. for a total consideration of approximately $108 million.
M&A
Medco Containment
Placed $150 million convertible debentures.
Capital Raise
Medical Marketing Group, Inc.
Advised on the initial public offering of common stock.
Capital Raise
Medical Marketing Group, Inc.
Placed $50 million convertible debentures.
Capital Raise
The Mediplex Group, Inc.
Advised on the initial public offering of common stock.
Capital Raise
National Home Health Care Corp.
Initiated and partnered with Angelo, Gordon & Co. on going-private acquisition (NASDAQ: NHHC).
M&A & Merchant Banking
National Rehabilitation Centers, Inc.
Advised on initial public offering of common stock.
Capital Raise
Orthopedic Systems, Inc.
Advised on the sale of their interest to Mizuho Corporation.
M&A
Osteotech, Inc.
Advised on private placement of approx. $8 million.
Capital Raise
Pacific Pharmacy, Inc.
Advised on an equity private placement.
Capital Raise
Pacific Pharmacy, Inc.
Advised on a debt recapitalization.
Capital Raise
Pharmacia & Upjohn
Advised on $2 billion secondary offerring.
Capital Raise
Pioneer Hi-Bred International, Inc.
Provided expert testimony during litigation.
Consulting
Shield Healthcare, Inc.
Advised management on and assisted in raising financing for buyout of controlling interest from Kobayashi Pharmaceuticals Co., Ltd.
M&A & Capital Raise
South Bay Medical, LLC
Advised on its sale to Mentor Corporation for approximately $28 million.
M&A
Sunrise IV Senior Living Holdings, LLC (The Fountains)
Advised the senior bank group on an out-of-court restructuring.
Restructuring
T2 Medical, Inc.
Advised on a secondary offering of common stock.
Capital Raise
Ultrabridge, Inc.
Advised on its sale to CareCentric, Inc.
M&A
Undisclosed Health Care IT Services Company
Advised on the sale of the company.
M&A
Undisclosed Home Health Co.
Structured, raised capital and advised on a 100% ESOP buyout.
ESOP
Undisclosed Long-Term Care Company
Provided valuation services.
Valuation & Fairness
Undisclosed Pharmaceutical Co.
Advised on a proposed joint venture with a Japanese pharmaceutical company.
Consulting
Undisclosed Private Pharmaceutical Co.
Advised on global licensing alternatives for a promising drug candidate in clinical development.
Consulting
USCB, Inc.
Structured, raised capital and advised on a 100% ESOP buyout
ESOP
Ventana Medical Systems, Inc.
Advised on its initial public offering of common stock.
Capital Raise
Ventana Medical Systems, Inc.
Provided a fairness opinion to the board of directors on its acquisition of Biotech Solutions, Inc.
Valuation & Fairness
Zenith Laboratories, Inc.
Advised on a secondary offering of common stock.
Capital Raise
